Home › NDC Lookup › RxCUI directory › RxCUI 2739511

Tradipitant 85 MG Oral Capsule — RxCUI 2739511

RxNorm drug concept · Semantic clinical drug
RxCUI 2739511 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2739511
Official nameTradipitant 85 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tradipitant: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nereus prevents vomiting caused by motion in adults. You take it ahead of an event likely to trigger it, such as a trip.
  • Take one dose by mouth about 60 minutes before your trip. Take it on an empty stomach, at least 1 hour before or 2 hours after a full meal. Don't take more than one dose in 24 hour...
  • It can. Sleepiness, headache and tiredness were the most common side effects. Don't drive or operate machinery until you know how it affects you.
  • Yes. Strong CYP3A4 inhibitors can raise your tradipitant level, and other drugs that cause drowsiness may add to the effect. Tell me about everything you take, and we'll check.
📖 Read our full Tradipitant guide →

🕸️ Concept Web — How Tradipitant 85 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tradipitant 85 MG Oral Capsule RxCUI 2739511

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tradipitant 2739506
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nereus 2739512
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tradipitant Oral Capsule 2739510
    • Tradipitant Oral Product 2739508
    • Tradipitant Pill 2739509
    • Tradipitant Oral Capsule [Nereus] 2739516
    • Nereus Oral Product 2739514
    • Nereus Pill 2739515
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tradipitant 85 MG SCDC · 2739507
  • Tradipitant Oral Capsule SCDF · 2739510
  • Tradipitant Oral Product SCDG · 2739508
  • Tradipitant Pill SCDG · 2739509

Brand-Name Concepts

  • Tradipitant 85 MG Oral Capsule [Nereus] SBD · 2739517
  • Tradipitant 85 MG [Nereus] SBDC · 2739513
  • Tradipitant Oral Capsule [Nereus] SBDF · 2739516
  • Nereus Oral Product SBDG · 2739514
  • Nereus Pill SBDG · 2739515
  • Nereus BN · 2739512

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2739511 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43068-0585-01 60 CARTON in 1 BOTTLE (43068-585-01) / 1 CAPSULE in 1 CARTO... NEREUS Vanda Pharmaceuticals Inc. 2026-03-31
43068-0585-02 36 CARTON in 1 BOTTLE (43068-585-02) / 1 CAPSULE in 1 CARTO... NEREUS Vanda Pharmaceuticals Inc. 2026-03-31
Observed labelers: Vanda Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.